Diagnostic Value of Myeloperoxidase Index in Bacterial Infections

Mirna Rahmafindari, Paulus Budiono Notopuro, Betty Agustina Tambunan

Abstract


Infectious diseases remain a serious problem in Indonesia. Myeloperoxidase (MPO) is a substance released by neutrophils, which activates the synthesis of hypochlorous acid (HOCL) from hydrogen peroxide (H2O2) and chloride ion (Cl-). Hypochlorous acid plays a vital role in the body's defense against infection. Myeloperoxidase Index (MPXI) is a parameter in the hematology analyzer Advia 2120i based on the principle of flow cytometry. This study aimed to determine the diagnostic value of MPXI in patients with bacterial infections. The study was a cross-sectional observational analysis. The samples consisted of a group of patients with bacterial infection and a group of healthy subjects. The specimens used in this study were whole blood + anticoagulant (EDTA) in a purple tube with a volume of 3 mL to determine the MPXI value in both groups using ADVIA 2120i hematology analyzer. The study subjects consisted of a group of patients with bacterial infections (69 patients) and a group of healthy subjects (33 people). Analysis of the MPXI ROC curve with a cut-off ≥ -5.8 and < -5.8, showed AUC of 0.323 (CI=95%, p=0.004), sensitivity of 34.8%, specificity of 39.4%, Positive Predictive Value (PPV) of 54.5%, and Negative Predictive Value (NPV) of 22.4%. Due to its low diagnostic value, the MPXI value was not recommended to be used as a diagnostic instrument for bacterial infections. Also, further research was highly needed.


Keywords


Myeloperoxdase index, myeloperoxidase, sensitivity, specificity, positive predictive value, the negative predictive value

Full Text:

PDF

References


Alladi M, Harikrishna J. Biomarkers for the diagnosis of

bacterial infections: In pursuit of the 'Holy Grail'. Indian

Journal of Medical Research. 2015; 141(13):271-273.

Werner JJ, Knights D, Garcia ML, Scalfone NB, Smith S, Yarasheski K, et al. Bacterial community structures are

unique and resilient in full-scale bioenergy systems.

Proc Natl Acad Sci, 2011; 108(10): 4158–63.

Duel G, Fabry J. Prevention of hospital-acquired

infections. World Health Organization 2002; 1–64.

Available: http://www.who.int/csr/resources/

publications/drugresist/en/whocdscsreph200212.pdf

?ua=1 (accessed 16 March, 2019).

Peres-Bota D, Rodriguez H, Dimopoulos G, DaRos A,

Mélot C, Struelens MJ, Vincent JL. Are infections due to

resistant pathogens associated with a worse outcome

in critically ill patients?. J Infect, 2003; 47: 307-16.

Klein A, Stein M, Golan-shany O, Kerem N, Srugo I,

Genizi J, et al. Validation of a novel assay to distinguish

bacterial and viral infections. Official Journal of the

American Academy of Pediatrics, 2017; 140.

Cha YS, Yoon JM, Jung WJ, Kim YW, Kim TH, et al.

Evaluation of usefulness of Myeloperoxidase Index

(MPXI) for differential diagnosis of Systemic

Inflammatory Response Syndrome (SIRS) in the

Emergency Department. Emerg Med J, 2015; 32(4):

–7.

Schwarz BC. Diagnostic value of the neutrophil

myeloperoxidase index in horses with systemic

inflammation. The Veterinary Journal, 2012; 191: 72-78.

Yonezawa K, Horie O, Yoshioka A, Matsuki S, Tenjin T,

Tsukamura Y, et al. Association between the

neutrophil myeloperoxidase index and subsets of

bacterial infections. Int J Lab Hematol, 2010; 32(Part 2):

–605.

Arifijanto M V. Sepsis. In: A. Tjokropprawiro A, et al.,

nd eds. Buku ajar ilmu penyakit dalam. 2 Ed., Surabaya,

Airlangga University Press, 2015; 701-707.

Stearns-Kurosawa DJ, Osuchowski MF, Valentine C,

Kurosawa S, Remick DG. The pathogenesis of sepsis.

Annu Rev Pathol, 2011; 6: 19-48.




DOI: http://dx.doi.org/10.24293/ijcpml.v27i2.1557

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.